Horizon Pharma to Host Conference Call and Webcast to Discuss Third Quarter 2012 Financial Results on November 13, 2012
(firmenpresse) - DEERFIELD, IL -- (Marketwire) -- 10/30/12 -- Horizon Pharma, Inc. (NASDAQ: HZNP) announced today that its third quarter 2012 financial results will be released on Tuesday, November 13, 2012. Following the announcement, Horizon's management will host a live conference call and webcast at 8:00 am Eastern Time to review the Company's financial and operating results and provide a general business update.
The live webcast and a replay may be accessed by visiting Horizon's website at . Please connect to the Company's website at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. Alternatively, please call 1-888-338-8373 (U.S.) or 973-872-3000 (international) to listen to the conference call. The conference ID number for the live call is 36414974. Telephone replay will be available approximately two hours after the call. To access the replay, please call 1-855-859-2056 (U.S.) or 404-537-3406 (international). The conference ID number for the replay is 36414974.
Horizon Pharma, Inc. is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. For more information, please visit .
Robert J. De Vaere
Executive Vice President and Chief Financial Officer
Investors
Kathy Galante
Burns McClellan, Inc.
212-213-0006
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 30.10.2012 - 06:30 Uhr
Sprache: Deutsch
News-ID 1165088
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
DEERFIELD, IL
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 163 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Horizon Pharma to Host Conference Call and Webcast to Discuss Third Quarter 2012 Financial Results on November 13, 2012
"
steht unter der journalistisch-redaktionellen Verantwortung von
Horizon Pharma (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
